We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
-4.57%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$614M
AUM Growth
-$80.1M
Cap. Flow
-$30.1M
Cap. Flow %
-4.9%
Top 10 Hldgs %
13.3%
Holding
146
New
29
Increased
54
Reduced
35
Closed
28

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$7.41M
2
DVAX
Dynavax Technologies
DVAX
+$7.06M
3
HDP
Hortonworks, Inc.
HDP
+$7.01M
4
EXLS icon
EXL Service
EXLS
+$6.89M
5
MSTR icon
Strategy Inc
MSTR
+$6.82M

Top Sells

Rank Stock Value
1
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$8.99M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$8.22M
3
SBNY
Signature Bank
SBNY
+$7.76M
4
JACK icon
Jack in the Box
JACK
+$7.43M
5
CSTE icon
Caesarstone
CSTE
+$7.21M

Sector Composition

Rank Sector Weight
1 Technology 30.4%
2 Healthcare 16.87%
3 Consumer Discretionary 15.79%
4 Industrials 12.8%
5 Financials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JACK icon
126
Jack in the Box
JACK
$358M
– –
-84,285
Closed -$7.43M
MCS icon
127
Marcus Corp
MCS
$914M
– –
-159,171
Closed -$3.05M
RGEN icon
128
Repligen
RGEN
$9.45B
– –
-171,942
Closed -$7.1M
SYNA icon
129
Synaptics
SYNA
$4.3B
– –
-66,298
Closed -$5.75M
VRNT
130
DELISTED
Verint Systems
VRNT
– –
-195,711
Closed -$6.06M
WEX icon
131
WEX
WEX
$6.48B
– –
-48,583
Closed -$5.54M
ITCI
132
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-257,256
Closed -$8.22M
MGLN
133
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-49,925
Closed -$3.5M
ONCE
134
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-110,288
Closed -$6.65M
LABL
135
DELISTED
Multi-Color Corp
LABL
– –
-103,773
Closed -$6.63M
CAB
136
DELISTED
Cabela's Inc
CAB
– –
-115,966
Closed -$5.8M
KATE
137
DELISTED
Kate Spade & Company
KATE
– –
-179,682
Closed -$3.87M
CLC
138
DELISTED
Clarcor
CLC
– –
-98,811
Closed -$6.15M
CPHD
139
DELISTED
Cepheid Inc
CPHD
– –
-106,388
Closed -$6.51M
PSG
140
DELISTED
Performance Sports Group Ltd.
PSG
– –
-168,888
Closed -$3.04M
RLYP
141
DELISTED
RELYPSA INC COM
RLYP
– –
-81,290
Closed -$2.69M
RENT
142
DELISTED
RENTRAK CORP
RENT
– –
-98,033
Closed -$6.84M
CYT
143
DELISTED
CYTEC INDS INC
CYT
– –
-116,419
Closed -$7.05M
YDLE
144
DELISTED
YODLEE INC COMMON STOCK
YDLE
– –
-227,690
Closed -$3.29M
SBNY
145
DELISTED
Signature Bank
SBNY
– –
-53,014
Closed -$7.76M
2 3 4 5
6

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MGM
Manchester Global Management London, United Kingdom $749M AUM 37.16% 1-Year Est. Return

Pier Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Pier Capital held 146 positions worth $614M, down 12% from $694M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Pier Capital withdrew a net $30.1M in Q3 2015, closing 28 positions and reducing 35 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $8.22M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Pier Capital opened a new position in AtriCure worth $6.5M.

  • Pier Capital's largest Q3 2015 buy was AtriCure: 296,688 shares worth $6.5M.
  • Pier Capital added most to The Brand House Collective in Q3 2015, an estimated $4.06M increase.
  • Pier Capital's biggest Q3 2015 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $8.99M.
  • Pier Capital fully exited Intra-Cellular Therapies Inc. in Q3 2015, selling an estimated $8.22M.
  • Pier Capital's ten largest holdings make up 13% of its $614M portfolio in Q3 2015.
  • Pier Capital opened 29 new positions and closed 28 in Q3 2015.
  • Pier Capital's portfolio value fell 12% quarter-over-quarter to $614M.

Based on Pier Capital's 13F filing for Q3 2015, filed 10 Nov 2015.